Twelve-month results of a Paclitaxel Releasing Balloon in Patients Presenting with In-stent Restenosis First-in-Man (PEPPER) trial

Cardiovascular Revascularization Medicine

Volumn 13, Issue 5, 2012, Pages 260-264

  Hehrlein, Christoph ^a   Dietz, Ulrich ^b   Kubica, Jacek ^c   Jørgensen, Erik ^d   Hoffmann, Ellen ^e   Naber, Christoph ^f   Lesiak, Maciej ^g   Schneider, Henrik ^h   Wiemer, Marcus ⁱ   Tölg, Ralph ^j   Richardt, Gert ^j  

^a UNIVERSITY OF FREIBURG   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^d University of Copenhagen   (Denmark)

^e KLINIKUM BOGENHAUSEN   (Germany)

^f ELISABETH KRANKENHAUS ESSEN   (Germany)

^g POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^h ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

ⁱ RUHR UNIVERSITY BOCHUM   (Germany)

^j Segeberger Kliniken   (Germany)

more..

Author keywords

Angioplasty; Balloon; Coronary restenosis; Paclitaxel

Indexed keywords

BUTYRYLTRI N HEXYL CITRATE; EXCIPIENT; PACLITAXEL; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY BYPASS; ARTICLE; BALLOON CATHETER; BARE METAL STENT; CORONARY ARTERY CIRCUMFLEX BRANCH; CRYSTAL STRUCTURE; DRUG SAFETY; FEMALE; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; LATE LUMEN LOSS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIGHT CORONARY ARTERY; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; BUTYRATES; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; EUROPE; EXCIPIENTS; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866178040     PISSN: 15538389     EISSN: 18780938     Source Type: Journal    
DOI: 10.1016/j.carrev.2012.06.002     Document Type: Article

References (27)

1. Stettler C., Wandel S., Allemann S., Kastrati A., Morice M.C., Schomig A., et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007, 370(9591):937-948.
2. Stone G.W., Moses J.W., Ellis S.G., Schofer J., Dawkins K.D., Morice M.C., et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007, 356(10):998-1008.
3. Dangas G.D., Claessen B.C., Caixeta A., Sanidas E.A., Mintz G.S., Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol 2010, 56(23):1897-1907.
4. Farooq V., Gogas B.D., Serruys P.W. Restenosis: delineating the numerous causes of drug-eluting stent restenosis. Circ Cardiovasc Interv 2011, 4(2):195-205.
5. Kastrati A., Byrne R. New roads, new ruts: lessons from drug-eluting stent restenosis. J Am Coll Cardiol Intv 2011, 4(2):165-167.
6. Steinberg D.H., Gaglia M.A., Pinto Slottow T.L., Roy P., Bonello L., et al. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol 2009, 103(4):491-495.
7. Scheller B., Hehrlein C., Bocksch W., Rutsch W., Haghi D., Dietz U., et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006, 355(20):2113-2124.
8. Waksmann R., Pakala R. Drug-eluting balloon: the comeback kid?. Circ Cardiovasc Interv 2009, 2(4):352-358.
9. Scheller B., Hehrlein C., Bocksch W., Rutsch W., Haghi D., Dietz U., et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2008, 97(10):773-781.
10. Habara S., Mitsudo K., Kadota K., Goto T., Fujii S., Yamamoto H., et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. J Am Coll Cardiol Intv 2011, 4(2):149-154.
11. Rittger H., Brachmann J., Sinha A.M., Waliszewski M., Ohlow M., Brugger A., et al. A Randomized, Multicenter, Single-Blinded Trial Comparing Paclitaxel-Coated Balloon Angioplasty With Plain Balloon Angioplasty in Drug-Eluting Stent Restenosis: The PEPCAD-DES Study. J Am Coll Cardiol 2012, [Epub ahead of print].
12. Scheller B., Clever Y.P., Kelsch B., Chem M., Hehrlein C., Bocksch W., Cremers B., et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. J Am Coll Cardiol Intv 2012, 5:323-330.
13. Unverdorben M., Vallbracht C., Cremers B., Heuer H., Hengstenberg C., Maikowski C., et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009, 119(23):2986-2994.
14. Hehrlein C., Richardt G., Wiemer M., Schneider H., Naber C., Hoffmann E., et al. Description of Pantera Lux paclitaxel-releasing balloon and preliminary quantitative coronary angiography (QCA) results at six months in patients with coronary in-stent restenosis. EuroIntervention 2011, 7:K119-K124.
15. Joner M., Byrne R.A., Lapointe J.M., Radke P.W., Bayer G., Steigerwald K., et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb Haemost 2011, 105(5):864-872.
16. Radke P.W., Joner M., Joost A., Byrne R.A., Hartwig S., Bayer G., et al. Vascular effects of paclitaxel following drug-eluting balloon angioplasty in a porcine coronary model: the importance of excipients. EuroIntervention 2011, 7(6):730-737.
17. Joner M., Radke P.W., Byrne R.A., Hartwig S., Steigerwald K., Leclerc G., et al. Preclinical evaluation of a novel drug-eluting balloon in an animal model of in-stent stenosis. J Biomater Appl 2012, [Epub ahead of print].
18. Mehran R., Dangas G., Abizaid A.S., Mintz G.S., Lansky A.J., Satler L.F., et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999, 100(18):1872-1878.
19. Cutlip D.E., Windecker S., Mehran R., Boam A., Cohen D.J., van Es G.A., et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115(17):2344-2351.
20. Thygesen K., Alpert J.S., White H.D. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Eur Heart J 2007, 28(20):2525-2538.
21. Fujii K., Mintz G.S., Kobayashi Y., Carlier S.G., Takebayashi H., Yasuda T., et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004, 109(9):1085-1088.
22. Kastrati A., Mehilli J., von B.N., Dibra A., Hausleiter J., Pache J., et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005, 293(2):165-171.
23. Mehilli J., Byrne R.A., Tiroch K., Pinieck S., Schulz S., Kufner S., et al. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study. J Am Coll Cardiol 2010, 55(24):2710-2716. ISAR-DESIRE 2 Investigators.
24. Alfonso F. Treatment of drug-eluting stent restenosis: the new pilgrimage: Quo vadis?. Am Col. Cardiol 2010, 55(24):2217-2720.
25. Nakazawa G., Otsuka F., Nakano M., Vorpahl M., Yazdani S.K., Ladich E., et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011, 57(11):1314-1322.
26. Stella P.R., Belkacemi A., Waksman R., Stahnke S., Torguson R., von Strandmann R.P., et al. The Valentines Trial: results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation DIOR paclitaxel drug-eluting balloon for in-stent restenosis treatment. EuroIntervention 2011, 7(6):705-710.
27. Alfonso F., Perez-Vizcayno M.J., Hernandez R., Bethencourt A., Marti V., Lopez-Minguez J.R., et al. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study. J Am Coll Cardiol 2008, 52(20):1621-1627.